[6,6] FUSED BICYCLIC HDAC8 INHIBITORS

The present invention is directed to compounds of Formula I:and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2′, L, X, W, Y1, Y2, Y3, and Y4 are described herein.

Saved in:
Bibliographic Details
Main Authors Lancia, JR., David R, Han, Bingsong, Barczak, Nicholas, Bair, Kenneth W, Zablocki, Mary-Margaret, Thomason, Jennifer R, Ng, Pui Yee, Liu, Cuixian, Rudnitskaya, Aleksandra, Zheng, Xiaozhang
Format Patent
LanguageEnglish
Published 13.12.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to compounds of Formula I:and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2′, L, X, W, Y1, Y2, Y3, and Y4 are described herein.
Bibliography:Application Number: US201816003861